References
- Center for Behavioral Health Statistics and Quality (CBHSQ). Results from the 2015 national survey on drug use and health: detailed tables. http://www.samhsa.gov/data/sites/default/files/NSDUH-DetTabs-2015/NSDUH-DetTabs-2015/NSDUH-DetTabs-2015.htm. Published 2016. Accessed February 15, 2021.
- Center for Behavioral Health Statistics and Quality (CBHSQ). Treatment episode data set (TEDS): 2003-2013. National Admissions to Substance Abuse Treatment Services. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2015. BHSIS Series S-75, HHS Publication No. (SMA) 15-4934. https://wwwdasis.samhsa.gov/dasis2/teds_pubs/2013_teds_rpt_natl.pdf. Published 2015.
- Hasin DS. US epidemiology of cannabis use and associated problems. Neuropsychopharmacology. 2018;43(1):195–212.
- Winters KC, Lee CY. Likelihood of developing an alcohol and cannabis use disorder during youth: association with recent use and age. Drug Alcohol Depend. 2008;92(1–3):239–247.
- Hasin DS, Saha TD, Kerridge BT, et al. Prevalence of marijuana use disorders in the United States between 2001-2002 and 2012-2013. JAMA Psychiatry. 2015;72(12):1235–1242.
- Kassed CA, Levit KR, Hambrick MM. Hospitalizations related to drug abuse, 2005: statistical brief #39. Healthcare Cost and Utilization Project (HCUP) Statistical Briefs. Rockville, MD: Agency for Health Care Quality and Research; 2006. Accessed February 5, 2021.
- Legality of cannabis by U.S. jurisdiction. https://en.wikipedia.org/wiki/Legality_of_cannabis_by_U.S._jurisdiction. Page last edited on October 27, 2020: Wikipedia; 2020.
- Peterson C, Xu L, Mikosz CA, Florence C, Mack KA. US hospital discharges documenting patient opioid use disorder without opioid overdose or treatment services, 2011-2015. J Subst Abuse Treat. 2018; 92:35–39.
- Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45(6):613–619.
- Grucza RA, Abbacchi AM, Przybeck TR, Gfroerer JC. Discrepancies in estimates of prevalence and correlates of substance use and disorders between two national surveys. Addiction. 2007;102(4):623–629.
- FDA approves first drug comprised of an active ingredient derived from marijuana to treat rare, severe forms of epilepsy. Rockville, MD: U.S. Food and Drug Administration; 2018. https://www.fda.gov/news-events/press-announcements/fda-approves-first-drug-comprised-active-ingredient-derived-marijuana-treat-rare-severe-forms. Accessed June 25, 2018.
- Bradford AC, Bradford WD, Abraham A, Bagwell Adams G. Association between US state medical cannabis laws and opioid prescribing in the Medicare part D population. JAMA Intern Med. 2018;178(5):667–672.